Understanding Biologics Data Exclusivity Periods and Their Legal Implications
Biologics Data Exclusivity Periods play a critical role in the regulatory landscape of biopharmaceuticals, influencing market dynamics and innovation pathways. Understanding their legal foundations is essential for navigating the complex interplay between intellectual property and public health. How do these exclusivity periods vary across jurisdictions, and what implications do they have for biosimilar entry and…